Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 (ECZema TRAlokinumab Trial no. 3)

Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Drug: Placebo Sponsor:   LEO Pharma Not yet recruiting

Source: ClinicalTrials.gov - December 6, 2017 Category: Research Source Type: clinical trials